CNSP — CNS Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $2.35m
- $2.10m
Annual cashflow statement for CNS Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.88 | -9.46 | -14 | -15.3 | -18.9 |
| Depreciation | |||||
| Non-Cash Items | 0.747 | 1.29 | 1.72 | 1.54 | 1.01 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.426 | 0.834 | -1.24 | 3.16 | 3.7 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -3.55 | -7.32 | -13.5 | -10.6 | -14.1 |
| Capital Expenditures | -0.02 | -0.018 | -0.006 | -0.004 | -0.004 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.02 | -0.018 | -0.006 | -0.004 | -0.004 |
| Financing Cash Flow Items | 0 | -0.045 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.3 | 14.1 | 4.51 | 15.6 | 4.64 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.69 | 6.8 | -9.03 | 5.05 | -9.51 |